Alcohol-related liver disease has more than doubled in the U.S. over the last 20 years.

Americans who drink heavily are more than twice as likely to develop significant liver disease compared to 20 years ago, ...

Metabolic dysfunction-associated steatotic liver disease is the leading driver of compensated advanced liver disease in the US.

Americans who drink heavily are more than twice as likely to develop significant liver disease compared to 20 years ago, ...

The aging liver undergoes dramatic changes in its functional organization and other key attributes, which may underpin its ...

The Global Liver Institute urges worldwide integration of liver health into diabetes and obesity care as steatotic liver disease surges.

Key takeaways: June 12 is Global Fatty Liver Day, an initiative aimed at increasing awareness of fatty liver disease. MASLD puts patients at increased risk for diabetes and other conditions.

How to recognize signs of nonalcoholic liver disease Weight-loss is a common treatment, but medication and surgery may be needed ...

New technology and drugs are transforming how doctors detect and treat silent liver disease MASLD before it leads to liver failure.

MASH, a preventable form of liver disease previously called nonalcoholic fatty liver disease, is caused by a buildup of visceral fat cells that accumulate on top of the internal organs, in this ...

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Pharmaceuticals, the British drugmaker said on Wednesday.